Liana Lucaric, MD
a user ...
a user ...
Write a review
Are you a patient of Liana Lucaric, MD?
5 out of 5 stars MonaLisa Touch
I am a breast cancer survivor of 6 years. Currently 56; Lumpectomy, stage 1, chemo, radiation, currently taking tamoxifen. The decline in my sex life was gradual. I felt very comfortable in talking about this with my oncologist. My husband has attended nearly every dr visit with me over the last six years. This topic was brought up in nearly every session. Once you get passed "all of the...
Undergraduate & Medical SchoolUndergraduate: University of California, Los Angeles
Medical: MD, Chicago Medical School
Post-Medical School TrainingResidency: Cook County Hospital
Treatments offered at Naperville Women's Healthcare
Most popular answers from Liana Lucaric, MD
MLT offers a two part treatment consisting of a vaginal treatment as well as a external treatment. Most patients are doing only the vaginal portion ... READ MORE
It is possible to experience increased discharge or light bleeding / brownish discharge after a mona lisa treatment. This would usually occur shortly ... READ MORE
Yes, the external vagina namely the vulvar area and area around the vaginal opening can be treated with MLT. This is most commonly done for patients... READ MORE
Itching is a common symptom after having the mona lisa touch procedure especially if you had an external treatment done at the same time. Itching ... READ MORE
Mona Lisa Touch is probably one of the best options for breast cancer patients who have few other choices for treatment of their vaginal and vulvar... READ MORE
I am 72 with severe atrophy to the point that I can no longer have pap smears because of the scarring. Could this help me?
Some women experience severe atrophy of the vagina and vulvar tissues during the course of menopause due to lack of estrogen to the tissues. Along ... READ MORE
Mona Lisa Touch is a noninvasive treatment most commonly used for symptoms of vaginal and vulvar atrophy related to hormonal changes associated with ... READ MORE
There is no recent activity.